Lupin Q4 net profit rises 35 pc to Rs 390 cr
The company had posted a net profit of Rs 289.56 crore for the corresponding period of the previous fiscal, Lupin said in a late…
Author
Two anti-inflammatory drugs may inhibit COVID-19 virus reproduction
The findings show that at a concentration of 50 micromolar (μM) of Celecoxib or Carprofen, the inhibition of the in vitro activity…
Chinese, US scientists identify bacterial secreted proteins that can inactivate coronavirus
This can provide a future avenue for the development of broad-spectrum antiviral drugs that might reduce the clinical burden…
Four COVID-19 vaccine candidates may enter clinical trials in three to five months: Health Minister
Financial support and regulatory clearance will be provided to those who are working on this, Vardhan assured.
New study finds high doses of vitamin D may not prevent or treat COVID-19
Researchers caution against over-supplementation of the vitamin, without medical supervision, due to health risks
French envoy says India will have key role in production of COVID-19 vaccine
India has already supplied 446 million hydroxychloroquine tablets and 1.54 billion paracetamol tablets to 133 countries, drawing…
First COVID-19 vaccine human trial finds it is safe, induces immune response
According to the study of 108 adults, the vaccine produced neutralising antibodies, and a response mediated by the immune system's…
Immense opportunities for pharma, med devices industries: CM Yogi Adityanath
UP chief minister was reviewing the presentation of the proposal of Pharma Park and Medical Device Park on Saturday
Dr Reddy’s PAT up 76 per cent in Q4, soft-launches HCQ in India
The performance was backed by tax deferment and growth in global generics, Dr Reddy's said
US pharma firm Gilead Sciences likely to seek nod to market anti-viral drug remdesivir in India
Officials of the Union Health Ministry, along with DCGI held a discussion with the representatives of Gilead Sciences to prepare a…